市场调查报告书
商品编码
1494448
北美伴侣动物诊断市场预测至 2030 年 - 区域分析 - 按技术、产品、应用、伴侣动物类型和最终用户North America Companion Animal Diagnostics Market Forecast to 2030 - Regional Analysis - by Technique, Product, Application, Companion Animal Type, and End User |
2022年北美伴侣动物诊断市场估值为11.931亿美元,预计2030年将达23.619亿美元;预计2022年至2030年复合年增长率为8.9%。
技术进步推动北美伴侣动物诊断市场
支持疾病早期发现的诊断技术的改进有助于宠物慢性病治疗取得更大成功。近年来,动物诊断技术的进步导致了更准确、更灵敏和更特异的诊断测试的发展。新一代定序 (NGS) 技术的使用是伴侣动物诊断领域的重大进步。 NGS 是一种强大的工具,可以快速、同时分析多个基因,从而能够识别可能与特定疾病相关的基因突变。 NGS 也为癌症、遗传性疾病和其他类似疾病提供了更灵敏、更特异的诊断测试。例如,MiDOG, LLC 推出了一种新的一体化微生物测试。该测试使用新一代 DNA 定序 (NGS) 来发现犬类样本上的各种细菌(厌氧和需氧)、真菌和抗生素抗药性。
此外,人工智慧 (AI) 和机器学习在伴侣动物诊断中的使用增加。人工智慧驱动的演算法可以在诊断中实施,以分析大量资料以识别模式并做出预测,这有助于提高诊断测试的准确性和效率。
北美伴侣动物诊断市场概述
北美伴侣动物诊断市场分为美国、加拿大和墨西哥。该地区市场的成长是由于政府对兽医研究和开发活动的支持不断增加、技术不断进步导致各种市场整合以及北美各国对宠物的采用不断增加。此外,伴侣动物诊断市场中各种市场领导者的出现预计将对预测期内的市场成长产生积极影响。
在美国,特定的兽医诊断受到监管并依赖美国农业部兽医生物製品中心 (USDA-CVB) 的批准。这些涉及兽医诊断试剂盒,旨在诊断接受治疗的动物的病原体。 USDA-CVB 是用于检测猫白血病病毒 (FeLV)、犬小病毒、犬心丝虫和其他病毒的即时诊断。国家兽医服务实验室为动物提供诊断服务,并提供围绕国内外动物疾病诊断的广泛诊断服务和资讯。该实验室也参与支持疾病控制和根除计画。它生产诊断测试试剂并提供培训和实验室认证。同样,还有隶属于美国兽医实验室诊断师协会的其他私人实验室。例如,威斯康辛州兽医诊断实验室为生产、伴侣和外来动物产业提供广泛的诊断服务。
北美伴侣动物诊断市场收入及 2030 年预测(百万美元)
北美伴侣动物诊断市场细分
北美伴侣动物诊断市场根据技术、产品、应用、伴侣动物类型、最终用户和国家进行细分。
根据技术,北美伴侣动物诊断市场分为免疫诊断、临床生物化学、分子诊断、尿液分析、血液学等。免疫诊断部分进一步分为横向测定、ELISA 测试、过敏原特异性免疫诊断测试和免疫分析仪。临床生化部分进一步分为临床生化分析、血糖监测及血液气体电解质分析。此外,生物化学部分分为PCR、微阵列等。
依产品划分,北美伴侣动物诊断市场分为仪器和消耗品。 2022 年,仪器仪表领域将占据更大的份额。
在应用方面,北美伴侣动物诊断市场分为细菌学、临床病理学、病毒学、寄生虫学等。 2022年,临床病理学领域占最大份额。
根据伴侣动物类型,北美伴侣动物诊断市场分为狗、猫、马等。 2022 年,狗类细分市场占据最大份额。
依最终用户划分,北美伴侣动物诊断市场分为诊断实验室、兽医医院和诊所、研究机构等。 2022 年,兽医院和诊所占最大份额。
按国家/地区划分,北美伴侣动物诊断市场分为美国、加拿大和墨西哥。 2022 年,美国将主导北美伴侣动物诊断市场。
Heska Corp、i-SENS Inc、Immunology Consultants Laboratory Inc、Zoetis Inc 和 Elabscience Biotechnology Inc 是北美伴侣动物诊断市场上的一些领先公司。
The North America companion animal diagnostics market was valued at US$ 1,193.10 million in 2022 and is expected to reach US$ 2,361.90 million by 2030; it is estimated to register a CAGR of 8.9% from 2022 to 2030.
Technological Advancements Fuel North America Companion Animal Diagnostics Market
Improvements in diagnostic technologies to support the early detection of diseases have contributed to the greater success of treatment of chronic diseases in pets. In recent years, technological advancements in animal diagnostics have resulted in the development of more accurate, sensitive, and specific diagnostic tests. The use of next-generation sequencing (NGS) technology is a significant advancement in companion animal diagnostics. NGS is a powerful tool that allows for the rapid and simultaneous analysis of multiple genes, enabling the identification of genetic mutations that may be linked to a specific disease. NGS has also unlocked more sensitive and specific diagnostic tests for cancer, hereditary diseases, and other similar diseases. For example, A new All-in-One Microbial Test has been introduced by MiDOG, LLC. The test finds every type of bacteria, both anaerobic and aerobic, fungus, and antibiotic resistance on canine specimens using next-generation DNA sequencing (NGS).
Moreover, there has been an increase in the use of artificial intelligence (AI) and machine learning in companion animal diagnostics. AI-powered algorithms can be implemented in diagnostics to analyze large volumes of data to identify patterns and make predictions, which can help improve the accuracy and efficiency of diagnostic tests.
North America Companion Animal Diagnostics Market Overview
The North America companion animal diagnostics market is divided into the US, Canada, and Mexico. The growth of the market in the region is due to rising government support for research and development activities in veterinary medicine, growing technological advancements that are resulting in various market consolidations, and rising adoption of pet animals across countries in North America. In addition, the presence of various market leaders in the companion animal diagnostics market is projected to influence the market growth positively during the forecast period.
In the US, specific veterinary diagnostics are regulated and dependent on the US Department of Agriculture-Center for Veterinary Biologics (USDA-CVB) for approval. These involve veterinary diagnostic kits intended to diagnose pathogens in animals undergoing treatment. USDA-CVB are point-of-care diagnostics for testing feline leukemia virus (FeLV), canine parvovirus, canine heartworm, and other viruses. The National Veterinary Services Laboratories provide diagnostics services for animals, and it offers a wide range of diagnostic services and information centered around the diagnosis of domestic and foreign animal diseases. The laboratory is also involved in the support of disease control and eradication programs. It produces reagents for diagnostic testing and offers training and laboratory certification. Similarly, there are presence other private laboratories affiliated to the American Association of Veterinary Laboratory Diagnosticians. For instance, the Wisconsin Veterinary Diagnostic Laboratory offers a broad range of diagnostic services to the production, companion, and exotic animal industries.
North America Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
North America Companion Animal Diagnostics Market Segmentation
The North America companion animal diagnostics market is segmented based on technique, product, application, companion animal type, end user, and country.
Based on technique, the North America companion animal diagnostics market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, urinalysis, hematology, and others. Immunodiagnostics segment is further categorized into lateral assays, ELISA tests, allergen-specific immunodiagnostics tests, and immunoassay analyzers. Clinical biochemistry segment is further categorized into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis. Also, biochemistry segment is categorized into PCR, microarray, and others.
By product, the North America companion animal diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger share in 2022.
In terms of application, the North America companion animal diagnostics market is segmented into bacteriology, clinical pathology, virology, parasitology, and others. The clinical pathology segment held the largest share in 2022.
Based on companion animal type, the North America companion animal diagnostics market is segmented into dogs, cats, horses, and others. The dogs segment held the largest share in 2022.
By end user, the North America companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals and clinics, research institutes, and others. The veterinary hospitals and clinics segment held the largest share in 2022.
Based on country, the North America companion animal diagnostics market is categorized into US, Canada, and Mexico. The US dominated the North America companion animal diagnostics market in 2022.
Heska Corp, i-SENS Inc, Immunology Consultants Laboratory Inc, Zoetis Inc, and Elabscience Biotechnology Inc are some of the leading companies operating in the North America companion animal diagnostics market.